Table 2.
Genotype |
Blood glucose, mg/dL |
Urinary glucose, µmol/mg creatinine |
FE-glucose, % |
Body weight, g |
Hematocrit, % |
Plasma creatinine, mg/dL |
Urine osmolality, mosm/kg |
Plasma osmolality, mosm/kg |
---|---|---|---|---|---|---|---|---|
WT | 151 ± 5 | 8.0 ± 0.6 | 0.10 ± 0.01 | 27.3 ± 0.7 | 43.1 ± 0.4 | 0.105 ± 0.002 | 1,736 ± 91 | 284 ± 3.3 |
Sglt2−/− | 122 ± 5* | 1,581 ± 124* | 26.2 ± 2.3* | 25.1 ± 0.4* | 44.7 ± 0.4* | 0.115 ± 0.004 (P = 0.058) | 1,455 ± 42* | 293 ± 3.5 (P = 0.079) |
Results are means ± SE; n = 14–18 mice/group. Baseline data were not significantly different between sham-operated and ischemia-reperfused groups for a given genotype and thus were pooled. WT, wild type; Sglt2−/−, Na+-glucose transporter 2 knockout; FE-glucose, fractional renal excretion of glucose.
P < 0.05 vs. WT mice using an unpaired t test.